AU2010231075B2 - Method for production of lactoferrin - Google Patents

Method for production of lactoferrin Download PDF

Info

Publication number
AU2010231075B2
AU2010231075B2 AU2010231075A AU2010231075A AU2010231075B2 AU 2010231075 B2 AU2010231075 B2 AU 2010231075B2 AU 2010231075 A AU2010231075 A AU 2010231075A AU 2010231075 A AU2010231075 A AU 2010231075A AU 2010231075 B2 AU2010231075 B2 AU 2010231075B2
Authority
AU
Australia
Prior art keywords
lactoferrin
lps
iron
endotoxins
milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010231075A
Other languages
English (en)
Other versions
AU2010231075A1 (en
Inventor
Jean-Paul Perraudin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2010231075A1 publication Critical patent/AU2010231075A1/en
Application granted granted Critical
Publication of AU2010231075B2 publication Critical patent/AU2010231075B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00—Processes
    • A23V2300/30—Ion-exchange
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00—Processes
    • A23V2300/34—Membrane process
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2010231075A 2009-01-28 2010-01-28 Method for production of lactoferrin Ceased AU2010231075B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20208809P 2009-01-28 2009-01-28
US61/202,088 2009-01-28
PCT/IB2010/000149 WO2010112988A1 (en) 2009-01-28 2010-01-28 Method for production of lactoferrin

Publications (2)

Publication Number Publication Date
AU2010231075A1 AU2010231075A1 (en) 2011-08-18
AU2010231075B2 true AU2010231075B2 (en) 2015-06-11

Family

ID=41818728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010231075A Ceased AU2010231075B2 (en) 2009-01-28 2010-01-28 Method for production of lactoferrin

Country Status (12)

Country Link
US (1) US9115211B2 (enExample)
EP (1) EP2391225B1 (enExample)
JP (1) JP5718254B2 (enExample)
CN (1) CN102348387B (enExample)
AU (1) AU2010231075B2 (enExample)
CA (1) CA2750701C (enExample)
DK (1) DK2391225T3 (enExample)
ES (1) ES2805279T3 (enExample)
NZ (1) NZ594212A (enExample)
PL (1) PL2391225T3 (enExample)
RU (1) RU2579661C2 (enExample)
WO (1) WO2010112988A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013204858B2 (en) 2012-10-08 2015-06-25 Saputo Dairy Australia Pty Limited Improved process for purifying milk proteins and products thereof
AU2013204850B2 (en) * 2012-10-08 2015-06-25 Murray Goulburn Co-Operative Co. Limited Improved process for purifying milk proteins and products thereof
RO130063A8 (ro) 2014-08-28 2017-06-30 Romvac Company S.A. Producerea şi utilizarea ovotransferinei moderne ()
WO2016136904A1 (ja) * 2015-02-26 2016-09-01 味の素株式会社 チーズの製造方法及びチーズ改質用の製剤
FR3046603B1 (fr) 2016-01-11 2017-12-29 Michelin & Cie Procede de modification d'un caoutchouc naturel et caoutchouc naturel modifie
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
US12594285B2 (en) 2016-02-25 2026-04-07 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
EP3419629A4 (en) 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
CN112996806A (zh) * 2018-11-06 2021-06-18 安赫尔工程建模有限责任公司 从奶、初乳和酸乳清或甜乳清中制备高纯度乳铁蛋白和乳过氧化物酶的方法
EP4098323A4 (en) 2020-01-30 2024-02-28 NRL Pharma, Inc. SANITARY PRODUCT CONTAINING LACTOFERRIN
AU2020203454B1 (en) * 2020-05-26 2021-07-22 HPS Tech Pty Ltd Processing protein
FR3115037B1 (fr) 2020-10-12 2025-02-21 Cie Laitiere Europeenne Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue
IL311036A (en) * 2021-08-23 2024-04-01 Lactea Therapeutics Llc Lactoferrin compositions and methods of use
KR20240078665A (ko) * 2021-08-23 2024-06-04 락테아 테라퓨틱스 엘엘씨 락토페린 조성물 및 사용 방법
AU2022390363A1 (en) * 2021-11-16 2024-06-13 Noumi Limited A method for producing a lactoferrin powder and uses thereof
DE202023102334U1 (de) 2023-04-28 2023-06-07 Mercurius Production Gmbh Lactoferrin und Vorrichtung zu dessen Herstellung
PL248495B1 (pl) * 2023-05-07 2025-12-22 Polmlek Spolka Z Ograniczona Odpowiedzialnoscia Sposób uzyskiwania laktoferyny w proszku z surowego mleka

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009706A1 (en) * 2007-07-10 2009-01-15 Glanbia Nutritionals Method for removing endotoxin from proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
JP2686831B2 (ja) * 1989-09-22 1997-12-08 雪印乳業株式会社 鉄結合性蛋白質を分離、精製し、採取する方法
US6096870A (en) * 1994-01-05 2000-08-01 Sepragen Corporation Sequential separation of whey
US5861491A (en) * 1994-02-16 1999-01-19 Pharming B.V. Isolation of lactoferrin from milk
JPH08217693A (ja) * 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
JP2974604B2 (ja) * 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JPH1059864A (ja) * 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
JP2002326950A (ja) * 2001-05-02 2002-11-15 Meiji Milk Prod Co Ltd 炎症性サイトカイン産生抑制剤
US20030096736A1 (en) * 2001-05-09 2003-05-22 Kruzel Marian L. Lactoferrin for age related disorders in humans
EP2286827A1 (en) * 2002-05-10 2011-02-23 Agennix Incorporated Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
AU2003233583A1 (en) * 2002-05-24 2003-12-12 Agennix Incorporated Oral lactoferrin in the treatment of respiratory disorders
US20070170061A1 (en) * 2004-02-03 2007-07-26 Kurume University Method for separating/refining cationic protein
US20090306350A1 (en) 2005-05-13 2009-12-10 Crea Biopharma Inc. New purification method of lactoferrin
JP5087297B2 (ja) * 2007-03-05 2012-12-05 森永乳業株式会社 インターロイキン−１１産生促進剤
CN101117351B (zh) * 2007-04-30 2010-08-18 北京济普霖生物技术有限公司 一种从转基因牛乳中纯化重组人乳铁蛋白的方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009009706A1 (en) * 2007-07-10 2009-01-15 Glanbia Nutritionals Method for removing endotoxin from proteins

Also Published As

Publication number Publication date
EP2391225A1 (en) 2011-12-07
EP2391225B1 (en) 2020-05-06
JP2012516319A (ja) 2012-07-19
RU2011135536A (ru) 2013-03-10
DK2391225T3 (da) 2020-07-20
CN102348387A (zh) 2012-02-08
CA2750701C (en) 2018-02-13
PL2391225T3 (pl) 2020-11-16
JP5718254B2 (ja) 2015-05-13
CN102348387B (zh) 2014-12-31
NZ594212A (en) 2013-01-25
US20110301077A1 (en) 2011-12-08
US9115211B2 (en) 2015-08-25
RU2579661C2 (ru) 2016-04-10
AU2010231075A1 (en) 2011-08-18
WO2010112988A1 (en) 2010-10-07
CA2750701A1 (en) 2010-10-07
ES2805279T3 (es) 2021-02-11

Similar Documents

Publication Publication Date Title
CA2750701C (en) Method for production of lactoferrin
SHIMAZAKI Lactoferrin: A marvelous protein in milk
CN101305017B (zh) 奶酪蛋白的酶水解产物中鉴定的生物活性肽及其生产方法
Rybarczyk et al. In vitro and in vivo studies on the antimicrobial effect of lactoferrin against Escherichia coli O157: H7
JP2013139477A (ja) 経口投与される剤
Kappeler et al. Sequence analysis of camel (Camelus dromedarius) lactoferrin
WO1993014640A1 (fr) Agent antibacterien et traitement d'articles au moyen de cet agent
JP2008532513A (ja) 金属イオンラクトフェリンの高圧処理
Ripolles et al. Antibacterial activity of bovine milk lactoferrin and its hydrolysates prepared with pepsin, chymosin and microbial rennet against foodborne pathogen Listeria monocytogenes
Kashyap et al. Identification of antibacterial and immunomodulatory bioactive peptides generated from buffalo (Bubalus bubalis) colostrum whey fermented by Lactobacillus rhamnosus C25: LC-MS/MS-based analysis
Jrad et al. Antilisterial activity of dromedary lactoferrin peptic hydrolysates
Du et al. Structure, function, and nutrition of lactoferrin
JPH05310594A (ja) 抗菌剤とこの抗菌剤を用いて物品を処理する方法
McCarthy et al. Bioactive peptides from casein and whey proteins
JP7454211B2 (ja) バクテリオファージ由来エンドライシン
Jean et al. Antimicrobial activity of buttermilk and lactoferrin peptide extracts on poultry pathogens
Ismael et al. Development of new strategy for non-antibiotic therapy: Dromedary camel lactoferrin has a potent antimicrobial and immunomodulator effects
Abdel-Salam et al. Effect of heat treatment on the chromatographic detection, electrophoretic pattern and antibacterial activity of lactoferrin purified from camel milk
Farnaud et al. Immunological System
Omara Antibacterial activity of papain hydrolysates of isoelectrically-isolated casein and thermoprecipitated alpha-lactalbumin from bovine and caprine milk on diarrheagenic bacteria
Akal et al. Dairy-derived antimicrobial substances: microorganisms, applications and recent trends
EP0889902B1 (en) Antibiotic peptides from bovine milk
Mehla Bioactive peptides in fermented milk products and their functionality
Naidu Ultra-cleansing of lactoferrin: Nutraceutical implications
Birukou et al. Industrial technology for producing recombinant lactofferin from the milk of transgenic goats.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired